Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.67 |
| ▸ | CA2 | P00918 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16952390 | 0.82 | CA1 (0.69) | CA1CA2MAPTALDH1A1MEN1 | |
| SCHEMBL470709 | 0.80 | CA1 (1.00) | CA1CA2MAPTALDH1A1MEN1 | |
| SCHEMBL60621 | 0.80 | CA1 (0.67) | CA1CA2MAPTALDH1A1MEN1 | |
| SCHEMBL16989324 | 0.78 | CA1 (0.65) | CA1CA2MAPTALDH1A1MEN1 | |
| SCHEMBL16989326 | 0.78 | CA1 (0.65) | CA1CA2MAPTALDH1A1MEN1 | |
| 2-Methoxyresorcinol SCHEMBL69297 | 0.78 | CA2 (0.61) | CA1CA2MAPTALDH1A1MEN1 | |
| SCHEMBL28576325 | 0.77 | CA1 (0.62) | CA1CA2MAPTALDH1A1MEN1 | |
| SCHEMBL2315019 | 0.76 | CA1 (0.61) | CA1CA2MAPTALDH1A1MEN1 | |
| SCHEMBL30372446 | 0.76 | CA1 (0.61) | CA1CA2MAPTALDH1A1MEN1 | |
| 2-Methoxyresorcinol SCHEMBL10818280 | 0.75 | CA2 (0.59) | CA1CA2MAPTALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8956624-B2 | Compositions and methods for treating skin with extract from Trametes | ELC MANAGEMENT, LLC (US) | 2015-02-17 | — | — | US | disclosed |
| US-20100203077-A1 | Compositions And Methods For Treating Skin With Extract From Trametes | ELC MANAGEMENT LLC | 2010-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100203077-A1 | Compositions And Methods For Treating Skin With Extract From Trametes | TYR, CUTA, BRAF | CA1 4883/4885CA2 4783/4885MAPT 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.